Oncimmune Holdings full year results and conference call

DirectorsTalk Interviews

Oncimmune Holdings plc (LON:ONC), the leading global immunodiagnostics group, states that it will be announcing its full year results for the year ended 31st May 2020 on Friday, 30 October 2020.

Adam Hill, Chief Executive Officer, together with Matthew Hall, Chief Financial Officer, will host a presentation and conference call for analysts at 11:30am GMT on the day of the results.

For conference call details please contact Alexander Davis of FTI Consulting at [email protected] or 020 3727 1000.

The management team will also host on Investor Meet Company a live presentation of the results on Friday, 30 October at 15:00 GMT.

• The online presentation will be open to all existing shareholders and potential new investors.

• Questions can be submitted before the event via your Investor Meet Company dashboard or at any time during the live presentation via the “Ask a Question” function. Responses to the Q&A will be published at the earliest opportunity on the Investor Meet Company platform.

• Investor feedback can also be submitted directly to management immediately following the event.

Access to Investor Meet Company is free and interested parties can register to attend the presentation via the following link: https://www.investormeetcompany.com/essensys-plc/register-investor

Attendees who have already registered on the Investor Meet Company platform to meet the Oncimmune Holdings will automatically receive an invitation to the presentation.

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:

Latest Company News

Sintana Energy agrees US$11m sale of Namibia licence stake to Chevron

Sintana Energy and its partners have agreed to sell a 10% stake in Namibia’s PEL 90 licence to Chevron for US$11m, retaining potential contingent payments ahead of further Orange Basin drilling.

Elemental Royalty agrees US$290m precious metals portfolio acquisition

Elemental Royalty has agreed a US$290m acquisition of five precious metals royalties and streams, expected to add US$15m to US$20m in annual revenue and expand its producing portfolio.

ICG Enterprise Trust: Investor questions answered and 1HFY’27 results

ICG Enterprise Trust reports accelerating portfolio company growth, 24 exits at an average 3.0x cost multiple and a 34% discount to NAV, as its manager discusses private equity opportunities, shareholder returns and the outlook for transaction activity.

Time Finance promotes invoice financing for working capital

Time Finance outlines how invoice financing can turn unpaid invoices into working capital to help businesses manage costs and support growth.

Ilika targets earlier commercialisation opportunities for Goliath solid-state batteries

Ilika is pursuing defence and e-bike applications to accelerate commercial opportunities for its Goliath solid-state batteries while continuing development for the electric vehicle market.

Biotech Growth Trust outperforms benchmark with 29% share price return

The Biotech Growth Trust PLC delivered a 29.0% share price total return and a 20.8% net asset value total return in the year to 30 September 2026. The share price return exceeded the NASDAQ Biotechnology Index’s 26.8% return, although the Trust’s NAV performance trailed the benchmark.

    Search